Biomee® Creams

About MC2 Therapeutics

MC2 Therapeutics is a specialized dermatology company leveraging its proprietary PAD Technology™ formulation platform to create advanced topical treatments for psoriasis and related inflammatory skin conditions. The company has transitioned to a commercial-stage entity with its lead product, Wynzora® Cream, approved in multiple regions including Canada, and is actively expanding through strategic partnerships in key markets like China and Australia. With a pipeline focused on immune-mediated skin diseases and a holistic approach to patient care, MC2 is positioning itself as a leader in next-generation topical drug delivery.

Therapeutic Areas